CP3-25616-65983 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-31
Dose 1 — Pfizer-BioNTech
2021-08-21
Dose 2 — Pfizer-BioNTech
2021-09-19
Registered in v-safe
2021-09-19
Survey response — day 28, dose 2
MedDRA: Caesarean section, Emergency care, Pre-eclampsia, Premature delivery — Feeling: Good · Be unable to work or attend school

Free text: Developed svwre preeclampsia at 34 weeks gestation and had to deliver early via emergency c section.

MedDRA releases: 2024-11 · check-in free text available
2021-09-25
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-10-02
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-11-20
Survey response — 3 months, dose 2
MedDRA: Urticaria — Feeling: Fair

Free text: Hives potentially from breastmilk.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-31	Pfizer-BioNTech	No
2	2021-08-21	Pfizer-BioNTech	No

Free text

Release 9 — day 28, dose 2

2021-09-19

Symptoms: Developed svwre preeclampsia at 34 weeks gestation and had to deliver early via emergency c section.

Release 10 — 3 months, dose 2

2021-11-20

Symptoms: Hives potentially from breastmilk.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Caesarean section	·	·	✓
SD	Emergency care	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Premature delivery	·	·	✓
SD	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release